Investors pulled $1.2 billion out of health care and biotech funds last week — the largest weekly outflow of money from the sector since February 2016, according to a new analysis.

The acceleration of investor money leaving biotech funds is reflected in plunging stock prices. The Nasdaq Biotech Index fell 4 percent in the five trading days ended on Feb. 7, the time period matching the $1.2 billion outflow. (Fund flows are reported on a Wednesday-to-Wednesday weekly schedule.)

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy